Role of the histone deacetylase complex in acute promyelocytic leukaemia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-02

AUTHORS

Richard J. Lin, Laszlo Nagy, Satoshi Inoue, Wenlin Shao, Wilson H. Miller, Ronald M. Evans

ABSTRACT

Non-liganded retinoic acid receptors (RARs) repress transcription of target genes by recruiting the histone deacetylase complex through a class of silencing mediators termed SMRT or N-CoR. Mutant forms of RARalpha, created by chromosomal translocations with either the PML (for promyelocytic leukaemia) or the PLZF (for promyelocytic leukaemia zinc finger) locus, are oncogenic and result in human acute promyelocytic leukaemia (APL). PML-RARalpha APL patients achieve complete remission following treatments with pharmacological doses of retinoic acids (RA); in contrast, PLZF-RARalpha patients respond very poorly, if at all. Here we report that the association of these two chimaeric receptors with the histone deacetylase (HDAC) complex helps to determine both the development of APL and the ability of patients to respond to retinoids. Consistent with these observations, inhibitors of histone deacetylase dramatically potentiate retinoid-induced differentiation of RA-sensitive, and restore retinoid responses of RA-resistant, APL cell lines. Our findings suggest that oncogenic RARs mediate leukaemogenesis through aberrant chromatin acetylation, and that pharmacological manipulation of nuclear receptor co-factors may be a useful approach in the treatment of human disease. More... »

PAGES

811-814

Journal

TITLE

Nature

ISSUE

6669

VOLUME

391

Related Patents

  • Carbamic Acid Compounds Comprising An Amide Linkage As Hdac Inhibitors
  • Carbamic Acid Compounds Comprising A Piperazine Linkage As Hdac Inhibitors
  • Pharmaceutical Formulations Of Hdac Inhibitors
  • Histone Deacetylases, And Uses Related Thereto
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Histone Deacetylase And Tubulin Deacetylase Inhibitors
  • Control Of Gene Expression
  • Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
  • Deacetylase Inhibitors And Uses Thereof
  • Bifunctional Histone Deacetylase Inhibitors
  • Class- And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Carbamic Acid Compounds Comprising A Sulfonamide Linkage As Hdac Inhibitors
  • Carbamic Acid Compounds Comprising An Ester Or Ketone Linkage As Hdac Inhibitors
  • Carbamic Acid Compounds Comprising A Sulfonamide Linkage As Hdac Inhibitors
  • Treatment Of Protein Degradation Disorders
  • Tricyclic Derivatives As Potent And Selective Histone Deacetylase Inhibitors
  • Carbamic Acid Compounds Comprising An Amide Linkage As Hdac Inhibitors
  • Oxabicycloheptanes And Oxabicylcoheptenes, Their Preparation And Use
  • Pharmaceutical Formulations Of Hdac Inhibitors
  • Crystal Structure Of A Deacetylase And Inhibitors Thereof
  • Histone Deacetylases, And Uses Related Thereto
  • Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
  • Histone Deacetylase (Hdac) Inhibitors For The Treatment Of Cancer
  • Hdac Inhibitors
  • Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
  • Histone Deacetylases, And Uses Related Thereto
  • Bifunctional Histone Deacetylase Inhibitors
  • Histone Deacetylase Inhibitors And Methods For Producing The Same
  • Class-And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Methods For Predicting Chemosensitivity Or Chemoresistance
  • 2-Indolinone Derivatives As Multi-Target Protein Kinase Inhibitors And Histone Deacetylase Inhibitors
  • Cloning Of The Human Nuclear Receptor Co-Repressor Gene
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Histone Deacetylase, And Uses Therefor
  • Histone Deacetylase Inhibitors
  • Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
  • Neuroprotective Agents For The Prevention And Treatment Of Neurodegenerative Diseases
  • Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors And Histone Deacetylase Inhibitors
  • Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
  • Selective Inhibitors Of Histone Deacetylase
  • Histone Deacetylase (Hdac) Inhibitors (Pxd101) For The Treatment Of Cancer Alone Or In Combination With Chemotherapeutic Agent
  • Neuroprotective Agents For The Prevention And Treatment Of Neurodegenerative Diseases
  • Treatment Of Protein Degradation Disorders
  • Carbamic Acid Compounds Comprising A Bicyclic Heteroaryl Group As Hdac Inhibitors
  • Histone Deacetylase Inhibitor And Process For Producing The Same
  • Selective Inhibitors Of Histone Deacetylase
  • Class- And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Histone Deacetylase Inhibitors
  • Smrt Co-Repressors, Transcriptional Co-Repressors That Interact With Nuclear Hormone Receptors
  • Hdac Inhibitors
  • Carbamic Acid Compounds Comprising A Sulfonamide Linkage As Hdac Inhibitors
  • Carbamic Acid Compounds Comprising A Piperazine Linkage As Hdac Inhibitors
  • Combined Use Of Prame Inhibitors And Hdac Inhibitors
  • Carbamic Acid Compounds Comprising A Sulfonamide Linkage As Hdac Inhibitors
  • Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
  • Pharmaceutical Formulations Of Hdac Inhibitors
  • Histone Deacetylases, And Uses Related Thereto
  • Histone Deacetylases, And Uses Related Thereto
  • Chd5 Encoding Nucleic Acids, Polypeptides, Antibodies And Methods Of Use Thereof
  • Deacetylase Inhibitors And Uses Thereof
  • Carbamic Acid Compounds Comprising A Bicyclic Heteroaryl Group As Hdac Inhibitors
  • Carbamic Acid Compounds Comprising An Ether Linkage As Hdac Inhibitors
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/35895

    DOI

    http://dx.doi.org/10.1038/35895

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048312080

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9486654


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cloning, Molecular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA-Binding Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Resistance, Neoplasm", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Escherichia coli", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoiesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Histone Deacetylase Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Histone Deacetylases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hydroxamic Acids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukemia, Promyelocytic, Acute", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nuclear Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nuclear Receptor Co-Repressor 2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oncogene Proteins, Fusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Retinoic Acid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Repressor Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retinoic Acid Receptor alpha", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Saccharomyces cerevisiae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Saccharomyces cerevisiae Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tretinoin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Suppressor Proteins", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of California, San Diego", 
              "id": "https://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "*Howard Hughes Medical Institute, La Jolla, California 92037, USA", 
                "\u2020The Salk Institute for Biological Studies, La Jolla, California 92037, USA", 
                "\u2021Graduate Program in Molecular Pathology, University of California San Diego, School of Medicine, La Jolla, California 92093, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lin", 
            "givenName": "Richard J.", 
            "id": "sg:person.01044244077.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044244077.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Salk Institute for Biological Studies", 
              "id": "https://www.grid.ac/institutes/grid.250671.7", 
              "name": [
                "*Howard Hughes Medical Institute, La Jolla, California 92037, USA", 
                "\u2020The Salk Institute for Biological Studies, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nagy", 
            "givenName": "Laszlo", 
            "id": "sg:person.014327773300.76", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014327773300.76"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Salk Institute for Biological Studies", 
              "id": "https://www.grid.ac/institutes/grid.250671.7", 
              "name": [
                "\u2020The Salk Institute for Biological Studies, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Inoue", 
            "givenName": "Satoshi", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "McGill University", 
              "id": "https://www.grid.ac/institutes/grid.14709.3b", 
              "name": [
                "\u00a7Lady Davis Institute for Medical Research, McGill University Departments of Oncology and Medicine, Montreal, Quebec, Canada H3T 1E2"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shao", 
            "givenName": "Wenlin", 
            "id": "sg:person.01146412423.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146412423.61"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Miller", 
            "givenName": "Wilson H.", 
            "id": "sg:person.0707336465.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707336465.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Salk Institute for Biological Studies", 
              "id": "https://www.grid.ac/institutes/grid.250671.7", 
              "name": [
                "*Howard Hughes Medical Institute, La Jolla, California 92037, USA", 
                "\u2020The Salk Institute for Biological Studies, La Jolla, California 92037, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Evans", 
            "givenName": "Ronald M.", 
            "id": "sg:person.012045455552.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012045455552.25"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/s0092-8674(00)80218-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001660495"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(91)90112-c", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004192344"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(91)90113-d", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005145371"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.92.16.7401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013491572"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.94.6.2551", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020668951"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.94.17.9028", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023652203"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/387043a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027015027", 
              "https://doi.org/10.1038/387043a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/377397a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027459196", 
              "https://doi.org/10.1038/377397a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.94.20.10762", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029558139"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.93.8.3624", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034380397"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(94)90340-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034614042"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(94)90341-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034615435"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/387049a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035667550", 
              "https://doi.org/10.1038/387049a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1128/mcb.17.8.4859", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036145694"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35901", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043182375", 
              "https://doi.org/10.1038/35901"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35901", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043182375", 
              "https://doi.org/10.1038/35901"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/377454a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048833155", 
              "https://doi.org/10.1038/377454a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(93)80044-f", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049479164"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1074/jbc.272.36.22447", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049950019"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.91.3.1178", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050487752"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/bies.950170510", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053154830"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1460-2075.1992.tb05095.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075467496"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077990249", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082494584", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082534459", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082741011", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1460-2075.1993.tb05757.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1082784710"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1460-2075.1993.tb05986.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1082788213"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082863250", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1083105696", 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1998-02", 
        "datePublishedReg": "1998-02-01", 
        "description": "Non-liganded retinoic acid receptors (RARs) repress transcription of target genes by recruiting the histone deacetylase complex through a class of silencing mediators termed SMRT or N-CoR. Mutant forms of RARalpha, created by chromosomal translocations with either the PML (for promyelocytic leukaemia) or the PLZF (for promyelocytic leukaemia zinc finger) locus, are oncogenic and result in human acute promyelocytic leukaemia (APL). PML-RARalpha APL patients achieve complete remission following treatments with pharmacological doses of retinoic acids (RA); in contrast, PLZF-RARalpha patients respond very poorly, if at all. Here we report that the association of these two chimaeric receptors with the histone deacetylase (HDAC) complex helps to determine both the development of APL and the ability of patients to respond to retinoids. Consistent with these observations, inhibitors of histone deacetylase dramatically potentiate retinoid-induced differentiation of RA-sensitive, and restore retinoid responses of RA-resistant, APL cell lines. Our findings suggest that oncogenic RARs mediate leukaemogenesis through aberrant chromatin acetylation, and that pharmacological manipulation of nuclear receptor co-factors may be a useful approach in the treatment of human disease.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/35895", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6669", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "391"
          }
        ], 
        "name": "Role of the histone deacetylase complex in acute promyelocytic leukaemia", 
        "pagination": "811-814", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e626d2636ebc7ca62dc589c924c8f4fe6834f9374b989e847fe24787d6596384"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9486654"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/35895"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048312080"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/35895", 
          "https://app.dimensions.ai/details/publication/pub.1048312080"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_53978_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/articles/35895"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/35895'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/35895'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/35895'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/35895'


     

    This table displays all metadata directly associated to this object as RDF triples.

    293 TRIPLES      21 PREDICATES      82 URIs      45 LITERALS      33 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/35895 schema:about N07c8e1bd3bec45669fc55c97165c9e37
    2 N20295d61753a42609c468d2cf392f6c3
    3 N223186ab8d7a4e448053e1ec444f2df0
    4 N28071ed670094a74828a64d77b123c54
    5 N595a680d9acc44e195e94d3e813e0772
    6 N66912d9a4ab04d7c911986753784d06a
    7 N7f2f762f4e6143b9b573925643b90c51
    8 N82f4ed1e9fb64de282aaf2426b3fac9a
    9 N8bd7dc0e843d4a20a12f8177346168ec
    10 N8fa8d7b1437b4792b11997ee9932f469
    11 N8fe51759bb744d63b36384c6ded8b4f9
    12 N95598986fc0041f39822d0222984e8ff
    13 Nc6f886e7748e48e9b0672903dfb4953f
    14 Nd55181a0246548aa83eab2e6fac9ddaa
    15 Nd606ef3eab7f474d9df30951be02026b
    16 Nd7f3640b70394514b814d4b716ae7046
    17 Nda2bebe7425d4c9f96f33a88a9db6f40
    18 Ndbb6eff7a3534a9da7bd3221f7605242
    19 Ne50ea556058a4563bef68c25e800fa78
    20 Ne7d171f171d14c80a7179b8c9f0be22b
    21 Ne8e5cc4ba63144a6bfc5b4bd8bbb516c
    22 Nf6c9060e1511423d8d739d29da391dea
    23 Nfadd2d60a8354d99b2f94c739111959b
    24 Nfcaebefb931e4dd5b464d81a998bd332
    25 anzsrc-for:11
    26 anzsrc-for:1112
    27 schema:author N1d933bccced742a6bbc058a4649c9f1e
    28 schema:citation sg:pub.10.1038/35901
    29 sg:pub.10.1038/377397a0
    30 sg:pub.10.1038/377454a0
    31 sg:pub.10.1038/387043a0
    32 sg:pub.10.1038/387049a0
    33 https://app.dimensions.ai/details/publication/pub.1077990249
    34 https://app.dimensions.ai/details/publication/pub.1082494584
    35 https://app.dimensions.ai/details/publication/pub.1082534459
    36 https://app.dimensions.ai/details/publication/pub.1082741011
    37 https://app.dimensions.ai/details/publication/pub.1082863250
    38 https://app.dimensions.ai/details/publication/pub.1083105696
    39 https://doi.org/10.1002/bies.950170510
    40 https://doi.org/10.1002/j.1460-2075.1992.tb05095.x
    41 https://doi.org/10.1002/j.1460-2075.1993.tb05757.x
    42 https://doi.org/10.1002/j.1460-2075.1993.tb05986.x
    43 https://doi.org/10.1016/0092-8674(91)90112-c
    44 https://doi.org/10.1016/0092-8674(91)90113-d
    45 https://doi.org/10.1016/0092-8674(93)80044-f
    46 https://doi.org/10.1016/0092-8674(94)90340-9
    47 https://doi.org/10.1016/0092-8674(94)90341-7
    48 https://doi.org/10.1016/s0092-8674(00)80218-4
    49 https://doi.org/10.1073/pnas.91.3.1178
    50 https://doi.org/10.1073/pnas.92.16.7401
    51 https://doi.org/10.1073/pnas.93.8.3624
    52 https://doi.org/10.1073/pnas.94.17.9028
    53 https://doi.org/10.1073/pnas.94.20.10762
    54 https://doi.org/10.1073/pnas.94.6.2551
    55 https://doi.org/10.1074/jbc.272.36.22447
    56 https://doi.org/10.1128/mcb.17.8.4859
    57 schema:datePublished 1998-02
    58 schema:datePublishedReg 1998-02-01
    59 schema:description Non-liganded retinoic acid receptors (RARs) repress transcription of target genes by recruiting the histone deacetylase complex through a class of silencing mediators termed SMRT or N-CoR. Mutant forms of RARalpha, created by chromosomal translocations with either the PML (for promyelocytic leukaemia) or the PLZF (for promyelocytic leukaemia zinc finger) locus, are oncogenic and result in human acute promyelocytic leukaemia (APL). PML-RARalpha APL patients achieve complete remission following treatments with pharmacological doses of retinoic acids (RA); in contrast, PLZF-RARalpha patients respond very poorly, if at all. Here we report that the association of these two chimaeric receptors with the histone deacetylase (HDAC) complex helps to determine both the development of APL and the ability of patients to respond to retinoids. Consistent with these observations, inhibitors of histone deacetylase dramatically potentiate retinoid-induced differentiation of RA-sensitive, and restore retinoid responses of RA-resistant, APL cell lines. Our findings suggest that oncogenic RARs mediate leukaemogenesis through aberrant chromatin acetylation, and that pharmacological manipulation of nuclear receptor co-factors may be a useful approach in the treatment of human disease.
    60 schema:genre research_article
    61 schema:inLanguage en
    62 schema:isAccessibleForFree false
    63 schema:isPartOf N79fb26d4432d485d89256c96bde23f85
    64 Nf72d1d85757648508bc0cb6760f99290
    65 sg:journal.1018957
    66 schema:name Role of the histone deacetylase complex in acute promyelocytic leukaemia
    67 schema:pagination 811-814
    68 schema:productId N1ff0e63d9847446abb7ec8349c0adf91
    69 N441df69987414345ae4308b4d43ead43
    70 N72257a5faf1f4639b15129a3d22cc913
    71 Ndcc4d4a3806d4d4a964433619b8f2f5a
    72 Nfa90b5600ef947268cff8153d6c8d36b
    73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048312080
    74 https://doi.org/10.1038/35895
    75 schema:sdDatePublished 2019-04-11T12:11
    76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    77 schema:sdPublisher N3827818c38104143978b225219235a5e
    78 schema:url http://www.nature.com/articles/35895
    79 sgo:license sg:explorer/license/
    80 sgo:sdDataset articles
    81 rdf:type schema:ScholarlyArticle
    82 N07c8e1bd3bec45669fc55c97165c9e37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Leukemia, Promyelocytic, Acute
    84 rdf:type schema:DefinedTerm
    85 N0861b9acd2804ee080ac46afaf7b09ff rdf:first sg:person.012045455552.25
    86 rdf:rest rdf:nil
    87 N0dfa8459d22646948337836acd368917 rdf:first sg:person.014327773300.76
    88 rdf:rest Nc579032911244e38bb24062d881ce2ed
    89 N1d933bccced742a6bbc058a4649c9f1e rdf:first sg:person.01044244077.26
    90 rdf:rest N0dfa8459d22646948337836acd368917
    91 N1ff0e63d9847446abb7ec8349c0adf91 schema:name dimensions_id
    92 schema:value pub.1048312080
    93 rdf:type schema:PropertyValue
    94 N20295d61753a42609c468d2cf392f6c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    95 schema:name Repressor Proteins
    96 rdf:type schema:DefinedTerm
    97 N223186ab8d7a4e448053e1ec444f2df0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    98 schema:name Receptors, Retinoic Acid
    99 rdf:type schema:DefinedTerm
    100 N28071ed670094a74828a64d77b123c54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Saccharomyces cerevisiae Proteins
    102 rdf:type schema:DefinedTerm
    103 N3827818c38104143978b225219235a5e schema:name Springer Nature - SN SciGraph project
    104 rdf:type schema:Organization
    105 N3fa26944960e4d2b9234af4ada05a0fd rdf:first sg:person.01146412423.61
    106 rdf:rest Nb74ad5dc9eea435ca262316d208ea653
    107 N441df69987414345ae4308b4d43ead43 schema:name nlm_unique_id
    108 schema:value 0410462
    109 rdf:type schema:PropertyValue
    110 N595a680d9acc44e195e94d3e813e0772 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Escherichia coli
    112 rdf:type schema:DefinedTerm
    113 N66912d9a4ab04d7c911986753784d06a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Saccharomyces cerevisiae
    115 rdf:type schema:DefinedTerm
    116 N72257a5faf1f4639b15129a3d22cc913 schema:name pubmed_id
    117 schema:value 9486654
    118 rdf:type schema:PropertyValue
    119 N79fb26d4432d485d89256c96bde23f85 schema:volumeNumber 391
    120 rdf:type schema:PublicationVolume
    121 N7f2f762f4e6143b9b573925643b90c51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Hydroxamic Acids
    123 rdf:type schema:DefinedTerm
    124 N82f4ed1e9fb64de282aaf2426b3fac9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Antineoplastic Agents
    126 rdf:type schema:DefinedTerm
    127 N8bd7dc0e843d4a20a12f8177346168ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Hematopoiesis
    129 rdf:type schema:DefinedTerm
    130 N8fa8d7b1437b4792b11997ee9932f469 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Nuclear Receptor Co-Repressor 2
    132 rdf:type schema:DefinedTerm
    133 N8fe51759bb744d63b36384c6ded8b4f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Transcription Factors
    135 rdf:type schema:DefinedTerm
    136 N95598986fc0041f39822d0222984e8ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Cell Line
    138 rdf:type schema:DefinedTerm
    139 Nb74ad5dc9eea435ca262316d208ea653 rdf:first sg:person.0707336465.30
    140 rdf:rest N0861b9acd2804ee080ac46afaf7b09ff
    141 Nc579032911244e38bb24062d881ce2ed rdf:first Ncf32cb6450b74e75b92700bf23d7e6ba
    142 rdf:rest N3fa26944960e4d2b9234af4ada05a0fd
    143 Nc6f886e7748e48e9b0672903dfb4953f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Histone Deacetylase Inhibitors
    145 rdf:type schema:DefinedTerm
    146 Ncf32cb6450b74e75b92700bf23d7e6ba schema:affiliation https://www.grid.ac/institutes/grid.250671.7
    147 schema:familyName Inoue
    148 schema:givenName Satoshi
    149 rdf:type schema:Person
    150 Nd55181a0246548aa83eab2e6fac9ddaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Retinoic Acid Receptor alpha
    152 rdf:type schema:DefinedTerm
    153 Nd606ef3eab7f474d9df30951be02026b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Drug Resistance, Neoplasm
    155 rdf:type schema:DefinedTerm
    156 Nd7f3640b70394514b814d4b716ae7046 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name DNA-Binding Proteins
    158 rdf:type schema:DefinedTerm
    159 Nda2bebe7425d4c9f96f33a88a9db6f40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Tumor Suppressor Proteins
    161 rdf:type schema:DefinedTerm
    162 Ndbb6eff7a3534a9da7bd3221f7605242 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Enzyme Inhibitors
    164 rdf:type schema:DefinedTerm
    165 Ndcc4d4a3806d4d4a964433619b8f2f5a schema:name doi
    166 schema:value 10.1038/35895
    167 rdf:type schema:PropertyValue
    168 Ne50ea556058a4563bef68c25e800fa78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Cloning, Molecular
    170 rdf:type schema:DefinedTerm
    171 Ne7d171f171d14c80a7179b8c9f0be22b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Neoplasm Proteins
    173 rdf:type schema:DefinedTerm
    174 Ne8e5cc4ba63144a6bfc5b4bd8bbb516c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Tretinoin
    176 rdf:type schema:DefinedTerm
    177 Nf6c9060e1511423d8d739d29da391dea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Histone Deacetylases
    179 rdf:type schema:DefinedTerm
    180 Nf72d1d85757648508bc0cb6760f99290 schema:issueNumber 6669
    181 rdf:type schema:PublicationIssue
    182 Nfa90b5600ef947268cff8153d6c8d36b schema:name readcube_id
    183 schema:value e626d2636ebc7ca62dc589c924c8f4fe6834f9374b989e847fe24787d6596384
    184 rdf:type schema:PropertyValue
    185 Nfadd2d60a8354d99b2f94c739111959b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Nuclear Proteins
    187 rdf:type schema:DefinedTerm
    188 Nfcaebefb931e4dd5b464d81a998bd332 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Oncogene Proteins, Fusion
    190 rdf:type schema:DefinedTerm
    191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    192 schema:name Medical and Health Sciences
    193 rdf:type schema:DefinedTerm
    194 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    195 schema:name Oncology and Carcinogenesis
    196 rdf:type schema:DefinedTerm
    197 sg:journal.1018957 schema:issn 0090-0028
    198 1476-4687
    199 schema:name Nature
    200 rdf:type schema:Periodical
    201 sg:person.01044244077.26 schema:affiliation https://www.grid.ac/institutes/grid.266100.3
    202 schema:familyName Lin
    203 schema:givenName Richard J.
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044244077.26
    205 rdf:type schema:Person
    206 sg:person.01146412423.61 schema:affiliation https://www.grid.ac/institutes/grid.14709.3b
    207 schema:familyName Shao
    208 schema:givenName Wenlin
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146412423.61
    210 rdf:type schema:Person
    211 sg:person.012045455552.25 schema:affiliation https://www.grid.ac/institutes/grid.250671.7
    212 schema:familyName Evans
    213 schema:givenName Ronald M.
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012045455552.25
    215 rdf:type schema:Person
    216 sg:person.014327773300.76 schema:affiliation https://www.grid.ac/institutes/grid.250671.7
    217 schema:familyName Nagy
    218 schema:givenName Laszlo
    219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014327773300.76
    220 rdf:type schema:Person
    221 sg:person.0707336465.30 schema:familyName Miller
    222 schema:givenName Wilson H.
    223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707336465.30
    224 rdf:type schema:Person
    225 sg:pub.10.1038/35901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043182375
    226 https://doi.org/10.1038/35901
    227 rdf:type schema:CreativeWork
    228 sg:pub.10.1038/377397a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027459196
    229 https://doi.org/10.1038/377397a0
    230 rdf:type schema:CreativeWork
    231 sg:pub.10.1038/377454a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048833155
    232 https://doi.org/10.1038/377454a0
    233 rdf:type schema:CreativeWork
    234 sg:pub.10.1038/387043a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027015027
    235 https://doi.org/10.1038/387043a0
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1038/387049a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035667550
    238 https://doi.org/10.1038/387049a0
    239 rdf:type schema:CreativeWork
    240 https://app.dimensions.ai/details/publication/pub.1077990249 schema:CreativeWork
    241 https://app.dimensions.ai/details/publication/pub.1082494584 schema:CreativeWork
    242 https://app.dimensions.ai/details/publication/pub.1082534459 schema:CreativeWork
    243 https://app.dimensions.ai/details/publication/pub.1082741011 schema:CreativeWork
    244 https://app.dimensions.ai/details/publication/pub.1082863250 schema:CreativeWork
    245 https://app.dimensions.ai/details/publication/pub.1083105696 schema:CreativeWork
    246 https://doi.org/10.1002/bies.950170510 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053154830
    247 rdf:type schema:CreativeWork
    248 https://doi.org/10.1002/j.1460-2075.1992.tb05095.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1075467496
    249 rdf:type schema:CreativeWork
    250 https://doi.org/10.1002/j.1460-2075.1993.tb05757.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1082784710
    251 rdf:type schema:CreativeWork
    252 https://doi.org/10.1002/j.1460-2075.1993.tb05986.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1082788213
    253 rdf:type schema:CreativeWork
    254 https://doi.org/10.1016/0092-8674(91)90112-c schema:sameAs https://app.dimensions.ai/details/publication/pub.1004192344
    255 rdf:type schema:CreativeWork
    256 https://doi.org/10.1016/0092-8674(91)90113-d schema:sameAs https://app.dimensions.ai/details/publication/pub.1005145371
    257 rdf:type schema:CreativeWork
    258 https://doi.org/10.1016/0092-8674(93)80044-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1049479164
    259 rdf:type schema:CreativeWork
    260 https://doi.org/10.1016/0092-8674(94)90340-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034614042
    261 rdf:type schema:CreativeWork
    262 https://doi.org/10.1016/0092-8674(94)90341-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034615435
    263 rdf:type schema:CreativeWork
    264 https://doi.org/10.1016/s0092-8674(00)80218-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001660495
    265 rdf:type schema:CreativeWork
    266 https://doi.org/10.1073/pnas.91.3.1178 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050487752
    267 rdf:type schema:CreativeWork
    268 https://doi.org/10.1073/pnas.92.16.7401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013491572
    269 rdf:type schema:CreativeWork
    270 https://doi.org/10.1073/pnas.93.8.3624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034380397
    271 rdf:type schema:CreativeWork
    272 https://doi.org/10.1073/pnas.94.17.9028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023652203
    273 rdf:type schema:CreativeWork
    274 https://doi.org/10.1073/pnas.94.20.10762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029558139
    275 rdf:type schema:CreativeWork
    276 https://doi.org/10.1073/pnas.94.6.2551 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020668951
    277 rdf:type schema:CreativeWork
    278 https://doi.org/10.1074/jbc.272.36.22447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049950019
    279 rdf:type schema:CreativeWork
    280 https://doi.org/10.1128/mcb.17.8.4859 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036145694
    281 rdf:type schema:CreativeWork
    282 https://www.grid.ac/institutes/grid.14709.3b schema:alternateName McGill University
    283 schema:name §Lady Davis Institute for Medical Research, McGill University Departments of Oncology and Medicine, Montreal, Quebec, Canada H3T 1E2
    284 rdf:type schema:Organization
    285 https://www.grid.ac/institutes/grid.250671.7 schema:alternateName Salk Institute for Biological Studies
    286 schema:name *Howard Hughes Medical Institute, La Jolla, California 92037, USA
    287 †The Salk Institute for Biological Studies, La Jolla, California 92037, USA
    288 rdf:type schema:Organization
    289 https://www.grid.ac/institutes/grid.266100.3 schema:alternateName University of California, San Diego
    290 schema:name *Howard Hughes Medical Institute, La Jolla, California 92037, USA
    291 †The Salk Institute for Biological Studies, La Jolla, California 92037, USA
    292 ‡Graduate Program in Molecular Pathology, University of California San Diego, School of Medicine, La Jolla, California 92093, USA
    293 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...